Conversion to sinus rhythm (cardioversion) is recommended to prevent t
he haemodynamic and thromboembolic complications of atrial fibrillatio
n. Prior anticoagulation is compulsory except in emergencies. The dura
tion of anticoagulant therapy depends on the terrain and chronicity of
the arrhythmia. Cardioversion may be proposed for the majority of pat
ients in whom it is thought that sinus rhythm can be maintained by app
ropriate therapy. It may be carried out pharmacologically by oral or i
ntravenous antiarrhythmic therapy. Amiodarone is the drug of choice. C
ardioversion may also be carried out by external or internal direct cu
rrent shock. The success rate of external electrical defibrillation de
pends on the energy administered, the site of the electrodes and a num
ber of factors related to thoracic impedence. Internal electrical defi
brillation may be performed with an endocavitary catheter or by the oe
sophageal approach, with few complications. The main problem resides i
n maintaining sinus rhythm in the long term. When this is not possible
, cardioversion is useless, and therapy to slow the cardiac rhythm sho
uld be instituted.